Avalyn Pharma completes $345 million IPO on nasdaq
Investing.com Gold reports: Avalyn Pharma completes $345 million IPO on nasdaq. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Avalyn Pharma completes $345 million IPO on nasdaq. Full body text was unavailable at ingest time, so this brief is based on headline context.